ArticleOncoimmunology

Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.

Abdulla Watad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.